Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

David A. Hyman, MD, JD, on Inclusive Shared Savings

Opportunities to Optimize Cancer Policies Panel Discussion

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement




Mar
25
Today In Oncology
FDA Approves Relacorilant With Nab-Paclitaxel for Several Platinum-Resistant Gynecologic Cancers
Awareness of Alcohol-Cancer Link Holds Steady Despite Omission in New US Dietary Guidelines
Myelofibrosis Treatment Landscape Is Poised for Change
AI Model Classifies Challenging Thymic Epithelial Tumors
Study Finds Inferior Survival Among Black Patients With AML, Independent of Cytogenetic Risk
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo